Skip to main content
HR 1261 104th Congress House Foreign Trade and International Finance Breast cancer Chemotherapy Drugs Health Tariff Women

To provide for duty free treatment for entries and withdrawals of tamoxifen citrate after December 31, 1993, and before January 1, 1995.

Introduced: March 16, 1995 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 104th Congress ended
It never became law before the 104th Congress (1995–1996) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 21, 1995
Referred to the Subcommittee on Trade.
Mar 16, 1995
Referred to the House Committee on Ways and Means.
Mar 16, 1995
Sponsor introductory remarks on measure. (CR E619)
Mar 16, 1995
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Declares that, upon proper request filed with the Customs Service within a specified period, any entry or withdrawal from warehouse for consumption of tamoxifen citrate made after December 31, 1993, and before January 1, 1995, and with respect to which there would have been no duty if such entry or withdrawal had been made on or after January 1, 1995, shall be liquidated or reliquidated (refunded) as though such entry or withdrawal had been made on or after January 1, 1995.

What's happening now March 21, 1995

Referred to the Subcommittee on Trade.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Neal, Richard E.
Massachusetts · Mar 16, 1995
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1261: To provide for duty free treatment for entries and withdrawals of tamoxifen citrate after December 31, 1993, and before January 1, 1995.. 104th Congress. Open America. https://openamerica.io/bill/104-HR-1261/
MLA
"H.R. 1261: To provide for duty free treatment for entries and withdrawals of tamoxifen citrate after December 31, 1993, and before January 1, 1995.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HR-1261/.
Bluebook (legal)
H.R. 1261, 104th Cong. (2026), https://openamerica.io/bill/104-HR-1261/.
Markdown link
[H.R. 1261: To provide for duty free treatment for entries and withdrawals of tamoxifen citrate after December 31, 1993, and before January 1, 1995.](https://openamerica.io/bill/104-HR-1261/)
Report a problem